Recent advances in the molecular modeling of estrogen receptor-mediated toxicity

Advances in Protein Chemistry and Structural Biology

Volumn 85, Issue , 2011, Pages 217-251

  Tsakovska, Ivanka ^a   Pajeva, Ilza ^a   Alov, Petko ^a   Worth, Andrew ^b  

^a INSTITUTE OF BIOPHYSICS AND BIOMEDICAL ENGINEERING   (Bulgaria)

^b JOINT RESEARCH CENTRE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052804303     PISSN: 18761623     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386485-7.00006-5     Document Type: Chapter

References (82)

1. G.M. Anstead, K.E. Carlson, and J.A. Katzenellenbogen The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site Steroids 62 1997 268 303 (Pubitemid 27114399)
2. S. Brogi, M. Kladi, C. Vagias, P. Papazafiri, V. Roussis, and A. Tafi Pharmacophore modeling for qualitative prediction of antiestrogenic activity J. Chem. Inf. Model. 49 2009 2489 2497
3. A.M. Brzozowski, A.C. Pike, Z. Dauter, R.E. Hubbard, T. Bonn, and O. Engström Molecular basis of agonism and antagonism in the oestrogen receptor Nature 389 1997 753 758 (Pubitemid 27458965)
4. Catalyst, Accelrys, Inc. 2005 San Diego, CA
5. L. Celik, J. Davey, D. Lund, and B. Schiøtt Exploring interactions of endocrine-disrupting compounds with different conformations of the human estrogen receptor α ligand binding domain: a molecular docking study Chem. Res. Toxicol. 21 2008 2195 2206
6. Z. Chen, H.L. Li, Q.J. Zhang, X.G. Bao, K.Q. Yu, and X.M. Luo Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets Acta Pharmacol. Sin. 30 2009 1694 1708
7. K. Connor, K. Ramamoorthy, M. Moore, M. Mustain, I. Chen, and S. Safe Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships Toxicol. Appl. Pharmacol. 145 1997 1111 1123
8. A. Demyttenaere-Kovatcheva, M.T. Cronin, E. Benfenati, A. Roncaglioni, and E. Lopiparo Identification of the structural requirements of the receptor-binding affinity of diphenolic azoles to estrogen receptors alpha and beta by three-dimensional quantitative structure-activity relationship and structure-activity relationship analysis J. Med. Chem. 48 2005 7628 7636 (Pubitemid 41699832)
9. J. Devillers, N. Marchand-Geneste, A. Carpy, and J.M. Porcher SAR and QSAR modeling of endocrine disruptors SAR QSAR Environ. Res. 17 2006 393 412 (Pubitemid 44277097)
10. P. D'Ursi, E. Salvi, P. Fossa, L. Milanesi, and E. Rovida Modelling the interaction of steroid receptors with endocrine disrupting chemicals BMC Bioinf. 6 Suppl. 4 2005 S10
11. EC Report of Proceedings of European Workshop on the Impact of Endocrine Disruptors on Human Health and Wildlife, Weybridge, UK, December 1996 1996 http://ec.europa.eu/environment/endocrine/documents/reports-conclusions-en.htm
12. S. Ekins, G. Bravi, S. Binkley, J.S. Gillespie, B.J. Ring, and J.H. Wikel Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors. Three and four dimensional- quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors Pharmacogenetics 9 1999 477 489
13. R.M. Evans The steroid and thyroid hormone receptor superfamily Science 240 1988 889 895
14. H. Fang, W. Tong, L.M. Shi, R. Blair, R. Perkins, and W. Branham Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens Chem. Res. Toxicol. 14 2001 280 294 (Pubitemid 32238488)
15. H. Fang, W. Tong, W.J. Welsh, and D.M. Sheehan QSAR models in receptor-mediated effects: the nuclear receptor superfamily J. Mol. Struct. (Theochem) 622 2003 113 125
16. R.A. Friesner, J.L. Banks, R.B. Murphy, T.A. Halgren, J.J. Klicic, and D.T. Mainz Glide: a new approach for rapid, accurate docking and scoring. Method and assessment of docking accuracy J. Med. Chem. 47 2004 1739 1749 (Pubitemid 38380917)
17. G. Cruciani Molecular Interaction Fields Applications in Drug Discovery and ADME Prediction 2006 Wiley-VCH Weinheim
18. P.J. Goodford A computational procedure for determining energetically favorable binding sites on biologically important macromolecules J. Med. Chem. 28 1985 849 857 (Pubitemid 15012490)
19. T.A. Grese, and J.A. Dodge Selective estrogen receptor modulators (SERMs) Curr. Pharm. Des. 4 1998 71 92 (Pubitemid 28090069)
20. H. Kubinyi 3D QSAR in Drug Design. Theory, Methods and Applications 1993 ESCOM Science Publishers B.V. Leiden
21. H.D. Höltje, W. Sippl, D. Rognan, and G. Folkers Virtual screening and docking Molecular Modeling: Basic Principles and Applications 2008 Wiley-VSH Weinheim
22. A.J. Hopfinger, S. Wang, J. Tokarski, B. Jin, M.A.B. Albuquerque, and P.J. Madhav Construction of 3D-QSAR models using the 4D-QSAR analysis formalism J. Am. Chem. Soc. 119 1997 10509 10524 (Pubitemid 27487990)
23. M.A. Islam, S. Nagar, S. Das, A. Mukherjee, and A. Saha Molecular design based on receptor-independent pharmacophore: application to estrogen receptor ligands Biol. Pharm. Bull. 31 2008 1453 1460 (Pubitemid 351930657)
24. A.N. Jain Effects of protein conformation in docking: improved pose prediction through protein pocket adaptation J. Comput. Aided Mol. Des. 23 2009 355 374
25. G. Jones, P. Willett, R.C. Glen, A.R. Leach, and R. Taylor Development and validation of a genetic algorithm for flexible docking J. Mol. Biol. 267 1997 727 748 (Pubitemid 27170693)
26. B.S. Katzenellenbogen Estrogen receptors: bioactivities and interactions with cell signaling pathways Biol. Reprod. 54 1996 287 293 (Pubitemid 26031396)
27. B.S. Katzenellenbogen, M. Montano, K. Ekena, M. Herman, and E. McInerney Antiestrogens: mechanisms of action and resistance in breast cancer Breast Cancer Res. Treat. 44 1997 23 38 (Pubitemid 27179766)
28. J.A. Katzenellenbogen, and R. Muthyala Interactions of exogenous endocrine active substances with nuclear receptors Pure Appl. Chem. 75 2003 1797 1817
29. R. Kavlock, G. Ankley, J. Blancato, M. Breen, R. Conolly, and D. Dix Computational toxicology - a state of the science mini review Toxicol. Sci. 103 2008 14 27 (Pubitemid 351524473)
30. G. Kellogg, S. Semus, and D. Abraham HINT: a new method of empirical hydrophobic field calculation for CoMFA J. Comput. Aided Mol. Des. 5 1991 545 552
31. G. Kiss, and N.W. Allen Automated docking of estrogens and SERMs into an estrogen receptor alpha and beta isoform using the PMF forcefield and the Lamarckian genetic algorithm Theor. Chem. Acc. 117 2007 305 314
32. G. Klebe Comparative molecular similarity indices analysis: CoMSIA H. Kubinyi, G. Folkers, Y. Martin, 3D QSAR in Drug Design. Recent Advances, vol. 3 1998 Kluwer/ESCOM Dordrecht 87 104 (Pubitemid 128488925)
33. A.J.S. Knox, Y. Yang, D.G. Lloyd, and M.J. Meegan Virtual screening of the estrogen receptor Expert Opin. Drug Discov. 3 2008 853 866
34. H. Kubinyi Lock and key in the real world: concluding remarks Pharm. Acta Helv. 69 1995 259 269
35. I.D. Kuntz, J.M. Blaney, S.J. Oatley, R. Langridge, and T.E. Ferrin A geometric approach to macromolecule-ligand interactions J. Mol. Biol. 161 1982 269 288
36. A.C. Layton, J. Sanseverino, B.W. Gregory, J.P. Easter, G.S. Sayler, and T.W. Schultz In vitro estrogen receptor binding of PCBs: measured activity and detection of hydroxylated metabolites in a recombinant yeast assay Toxicol. Appl. Pharmacol. 180 2002 157 163 (Pubitemid 34526456)
37. M. Lill, and A. Vedani Computatinal modeling of receptor mediated toxicity S. Ekins, Computational Toxicology: Risk Assessment for Pharmaceutical and Environmental Chemicals 2007 John Wiley & Sons Inc 315 352
38. M.A. Lill, M. Dobler, and A. Vedani In silico prediction of receptor-mediated environmental toxic phenomena - application to endocrine disruption SAR QSAR Environ. Res. 16 2005 149 169 (Pubitemid 40623247)
39. E. Lo Piparo, and A. Worth Review of QSAR Models and Software Tools for predicting Developmental and Reproductive Toxicity 2010 European Commission report EUR 24522 EN
40. J.C. Madden, and M.T.D. Cronin Three-dimensional molecular modelling of receptor-based mechanisms in toxicology M. Cronin, J. Madden, Silico Toxicology 2010 Royal Society of Chemistry Cambridge 210 227
41. M.R. McGann, H.R. Almond, A. Nicholls, J.A. Grant, and F.K. Brown Gaussian docking functions Biopolymers 68 2003 76 90 (Pubitemid 36098309)
42. N.J. McKenna, and B.W. O'Malley Combinatorial control of gene expression by nuclear receptors and coregulators Cell 108 2002 465 474 (Pubitemid 34260872)
43. J.A. McLachlan Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals Endocr. Rev. 22 2001 319 341 (Pubitemid 32554362)
44. C. McMartin, and R. Bohacek QXP: powerful, rapid computer algorithms for structure-based drug design J. Comput. Aided Mol. Des. 11 1997 333 344 (Pubitemid 127506740)
45. O. Mekenyan, and R. Serafimova Mechanism-based modeling of estrogen receptor binding affinity a common reactivity pattern (COREPA) implementation J. Devillers, Endocrine Disruption Modeling 2009 CRC Press Boca Raton 229 294
46. I.R.A. Menezes, A. Leitão, and C.A. Montanari Three-dimensional models of non-steroidal ligands: a comparative molecular field analysis Steroids 71 2006 417 428
47. S. Mocklinghoff, R. Rose, M. Carraz, A. Visser, C. Ottmann, and L. Brunsveld Synthesis and crystal structure of a phosphorylated estrogen receptor ligand binding domain Chembiochem 11 2010 2251 2254
48. MOE 2010.10 (Molecular Operating Environment), Chemical Computing Group, 1010 Sherbrooke Street West, Suite 910, Montreal, Quebec, Canada H3A 2R7.
49. G. Morris, D. Goodsell, R. Halliday, R. Huey, W. Hart, and R. Belew Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function J. Comput. Chem. 19 1998 1639 1662 (Pubitemid 128590223)
50. T. Nose, T. Tokunaga, and Y. Shimohigashi Exploration of endocrine-disrupting chemicals on estrogen receptor alpha by the agonist/antagonist differential-docking screening (AADS) method: 4-(1-Adamantyl)phenol as a potent endocrine disruptor candidate Toxicol. Lett. 191 2009 33 39
51. M. Pastor, G. Cruciani, I. McLay, S. Pickett, and S. Clementi Grid independent descriptors (GRIND). A novel class of alignment-independent three-dimensional molecular descriptors J. Med. Chem. 43 2000 3233 3243
52. T. Pencheva, D. Lagorce, I. Pajeva, B.O. Villoutreix, and M. Miteva AMMOS: automated molecular mechanics optimization tool for in silico screening BMC Bioinformatics 9 2008 438 452
53. A.C. Pike Lessons learnt from structural studies of the oestrogen receptor Best Pract. Res. Clin. Endocrinol. Metab. 20 2006 1 14 (Pubitemid 43328570)
54. A.C. Pike, A.M. Brzozowski, R.E. Hubbard, T. Bonn, A.G. Thorsell, and O. Engström Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist EMBO J. 18 1999 4608 4618 (Pubitemid 29415516)
55. J.R. Rabinowitz, M.R. Goldsmith, S.B. Little, and M.A. Pasquinelli Computational molecular modeling for evaluating the toxicity of environmental chemicals: prioritizing bioassay requirements Environ. Health Perspect. 116 2008 573 577
56. J.R. Rabinowitz, S.B. Little, and M.R. Goldsmith Molecular modeling for screening environmental chemicals for estrogenicity: Use of the toxicant-target approach Chem. Res. Toxicol. 22 2009 1594 1602
57. M. Rarey, B. Kramer, T. Lengauer, and G. Klebe A fast flexible docking method using an incremental construction algorithm J. Mol. Biol. 261 1996 470 489 (Pubitemid 26335901)
58. A. Roncaglioni, and E. Benfenati In silico-aided prediction of biological properties of chemicals: oestrogen receptor-mediated effects Chem. Soc. Rev. 37 2008 441 450
59. L. de B. Salum, I. Polikarpov, and A.D. Andricopulo Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies J. Mol. Graph. Model. 26 2007 434 442 (Pubitemid 47333209)
60. L. de B. Salum, I. Polikarpov, and A.D. Andricopulo Structure-based approach for the study of estrogen receptor binding affinity and subtype selectivity J. Chem. Inf. Model. 48 2008 2243 2253
61. G. Schneider, and K.H. Baringhaus Receptor-ligand interaction Molecular Design: Concepts and Applications 2008 Wiley-VCH Weinheim
62. R. Serafimova, M. Todorov, D. Nedelcheva, T. Pavlov, Y. Akahori, and M. Nakai QSAR and mechanistic interpretation of estrogen receptor binding SAR QSAR Environ. Res. 18 2007 389 421 (Pubitemid 46789503)
63. E.K. Shanle, and W. Xu Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action Chem. Res. Toxicol. 24 2011 6 19
64. D. Sivanesan, R.V. Rajnarayanan, J. Doherty, and N. Pattabiraman In-silico screening using flexible ligand binding pockets: a molecular dynamics-based approach J. Comput. Aided Mol. Des. 19 2005 213 228 (Pubitemid 41386819)
65. A.M. Soto, K.L. Chung, and C. Sonnenschein The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells Environ. Health Perspect. 102 1994 380 383 (Pubitemid 24164500)
66. J.P. Sumpter Xenoendocrine disrupters - environmental impacts Toxicol. Lett. 102-103 1998 337 342 (Pubitemid 29021242)
67. M. Taha, M. Tarairah, H. Zalloum, and G. Abu-Sheikha Pharmacophore and QSAR modeling of estrogen receptor β ligands and subsequent validation and in silico search for new hits J. Mol. Graph. Model. 28 2010 383 400
68. W. Tong, H. Fang, H. Hong, Q. Xie, R. Perkins, and J. Anson Workshop 1.2: regulatory application of SAR/QSAR for priority setting of endocrine disruptors: a perspective Pure Appl. Chem. 75 2003 2375 2388
69. A. Vedani, and M. Smiesko In silico toxicology in drug discovery - concepts based on three-dimensional models ATLA Altern. Lab. Anim. 37 2009 477 496
70. A. Vedani, H. Briem, M. Dobler, H. Dollinger, and D. McMasters Multiple-conformation and protonation-state representation in 4D-QSAR: the neurokinin-1 receptor system J. Med. Chem. 43 2000 4416 4427 (Pubitemid 32046866)
71. A. Vedani, M. Dobler, and M.A. Lill Combining protein modeling and 6D-QSAR - simulating the binding of structurally diverse ligands to the estrogen receptor J. Med. Chem. 48 2005 3700 3703 (Pubitemid 40776845)
72. A. Vedani, M. Dobler, and P. Zbinden Quasi-atomistic receptor surface models: a bridge between 3D-QSAR and receptor modeling J. Am. Chem. Soc. 120 1998 4471 4477 (Pubitemid 28261208)
73. A. Vedani, M. Dobler, and M. Lill The challenge of predicting drug toxicity in silico Basic Clin. Pharmacol. Toxicol. 99 2006 195 208 (Pubitemid 44321483)
74. A. Vedani, M. Smiesko, M. Spreafico, O. Peristera, and M. Dobler Virtual ToxLab in silico prediction of the toxic (endocrine-disrupting) potential of drugs, chemicals and natural products. Two years and 2,000 compounds of experience: a progress report ALTEX 26 2009 183 193
75. C.Y. Wang, N. Ai, S. Arora, E. Erenrich, K. Nagarajan, and R. Zauhar Identification of previously unrecognized antiestrogenic chemicals using a novel virtual screening approach Chem. Res. Toxicol. 19 2006 1595 1601 (Pubitemid 44975122)
76. G. Wolber, and T. Langer LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters J. Chem. Inf. Model. 45 2005 160 169 (Pubitemid 40736968)
77. S. Wold, M. Sjöström, and L. Eriksson PLS-regression: a basic tool of chemometrics Chemom. Intell. Lab. Syst. 58 2001 109 130 (Pubitemid 33033283)
78. P. Wolohan, and D. Reichert CoMSIA and docking study of rhenium based estrogen receptor ligand analogs Steroids 72 2007 247 260 (Pubitemid 46273506)
79. J.M. Wurtz, W. Bourguet, J.P. Renaud, V. Vivat, P. Chambon, and D. Moras A canonical structure for the ligand-binding domain of nuclear receptors Nat. Struct. Biol. 3 1996 87 94
80. A. Xiao, Z. Zhang, L. An, and Y. Xiang 3D-QSAR and docking studies of 3-arylquinazolinethione derivatives as selective estrogen receptor modulators J. Mol. Model. 14 2008 149 159
81. W. Yang, X. Liu, H. Liu, Y. Wu, J.P. Giesy, and H. Yu Molecular docking and comparative molecular similarity indices analysis of estrogenicity of polybrominated diphenyl ethers and their analogues Environ. Toxicol. Chem. 29 2010 660 668
82. Z. Zsoldos, D. Reid, A. Simon, B.S. Sadjad, and A.P. Johnson eHiTS: an innovative approach to the docking and scoring function problems Curr. Protein Pept. Sci. 7 2006 421 435 (Pubitemid 44524491)